Canan Yüksel Acar
Istanbul, 34752, Turkey (Türkiye)
NCT Number: NCT06555718
The main advantage of patient-to-patient peer counseling is that it benefits both the client and the peer mentors as real and authentic experiences are shared. Since both individuals go through similar experiences, they can share common feelings. Although there are studies in the literature showing the effectiveness of peer support groups in different patient groups, studies on chronic kidney disease patients are limited. There are no studies on the effects of these programs on caregivers. This study will be conducted to examine the effects of peer support program applied to chronic kidney patients on patient outcomes and caregivers.
This study is active but is not currently recruiting participants.
18 year–80 year
All sexes
Interventional
Not applicable
Istanbul, 34752, Turkey (Türkiye)
This study was planned to be conducted with a randomized controlled experimental design to examine the effect of the peer support program applied to Chronic Kidney patients on patient outcomes and caregivers.
Patients diagnosed with Chronic Kidney Disease and receiving haemodialysis (HD) as a renal replacement method constitute the population of the study. In the a priori power analysis performed to calculate the number of subjects, the effect size was taken as 1.3 (d) based on reference studies. Accordingly, it was found that 34 subjects should be included in the calculation for the independent two-sample t-test according to 0.95 power and 0.05 alpha. The sample of the study will consist of 25 intervention and 25 control CKDs who fulfil the inclusion criteria, taking into account the dropout status.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion and Exclusion Criteria For Peer Mentor Inclusion Criteria;
For Patient Inclusion Criteria;
Exclusion criteria
for all participants
Losses to follow-up
Implementation of the research; Peer support programme for the intervention group will be carried out for 10 weeks in accordance with the peer guide-client implementation plan. Standard follow-up and training programme will be applied to the control group in accordance with the procedures of the institution.
The standard care provided by the institution will continue.
Time frame: The scale will be completed before the intervention and at 3, 7 and 9 weeks.
"End Stage Renal Disease Adaptation Questionnaire (ESRD-AQ)" Total score varies between 0 and 1200. As the score obtained from the scale increases, the level of treatment compliance increases.
Time frame: The scale will be completed before the intervention and at 3, 7 and 9 weeks.
"Chronic Dialysis Patients' Self-Care Agency (SCA)" Scores obtained from the scale are between 0-44. As the score decreases, it is evaluated as self-care power is not good.
Time frame: The Kt/V value of all patients calculated before the intervention and the change in the value measured 3, 7 and 9 weeks after the intervention will be completed by the researcher.
"Data collection form for patients (The target Kt/V in dialysis patients is between 1.2-1.4. , Kt/V(K - urea dialyzer clearance, t - dialysis time, V - urea volume of distribution))"
Time frame: The scale will be completed by the patients before the intervention and at 9th week.
"Caregiver Burden Scale for family caregivers of hemodialysis patients" Sub-dimension scores, internal consistency of 0.87, 0.70, 0.76, 0.70, 0.70 and 0.53 indicate an increase in care burden.
Acibadem University
Other
Examining the Effect of the Peer Support Program Applied to Chronic Kidney Patients on Care Outcomes
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03119376
Peer Review
Paris, France
View Trial DetailsNCT02739737
Peer Review
View Trial DetailsNCT05834309
Behavior, Cognition Disorders
Pamplona, Navarre, Spain
View Trial DetailsNCT07176195
Behavior, Health Behavior
Ljubljana, Slovenia
View Trial Details